NeruoKyma offers the possibility to accurately test the effect of the drugs on brain activity and networks during clinical trials. By assisting in the design of experimental paradigm, NeuroKyma provides a full service of EEG analysis from data recordings, preprocessing to the extraction of network-based Neuromarkers. All of these steps are adapted according to the analyzed pathology.